Literature DB >> 21442129

High-Glucose Environment Inhibits p38MAPK Signaling and Reduces Human β-Defensin-3 Expression [corrected] in Keratinocytes.

Cheng-Che E Lan1, Ching-Shuang Wu, Shu-Mei Huang, Hsuan-Yu Kuo, I-Hui Wu, Chien-Hui Wen, Chee-Yin Chai, Ai-Hui Fang, Gwo-Shing Chen.   

Abstract

Diabetes mellitus is characterized by elevated plasma glucose and increased rates of skin infections. Altered immune responses have been suggested to contribute to this prevalent complication, which involves microbial invasion. In this study we explored the effects of a high-glucose environment on the innate immunity of keratinocytes by focusing on β defensin-3 (BD3) using in vivo and in vitro models. Our results demonstrated that the perilesional skins of diabetic rats failed to show enhanced BD3 expression after wounding. In addition, high-glucose treatment reduced human BD3 (hBD3) expression of cultured human keratinocytes. This pathogenic process involved inhibition of p38MAPK signaling, an event that resulted from increased formation of advanced glycation end products. On the other hand, toll-like receptor-2 expression and function of cultured keratinocytes were not significantly affected by high-glucose treatment. In summary, high-glucose conditions inhibited the BD3 expression of epidermal keratinocytes, which in turn contributed to the frequent occurrences of infection associated with diabetic wounding.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442129      PMCID: PMC3146598          DOI: 10.2119/molmed.2010.00091

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  41 in total

1.  Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases.

Authors:  E J Goldstein; D M Citron; C A Nesbit
Journal:  Diabetes Care       Date:  1996-06       Impact factor: 19.112

Review 2.  Lilly Lecture 1993. Glycation and diabetic complications.

Authors:  M Brownlee
Journal:  Diabetes       Date:  1994-06       Impact factor: 9.461

Review 3.  Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways.

Authors:  A J Whitmarsh; R J Davis
Journal:  J Mol Med (Berl)       Date:  1996-10       Impact factor: 4.599

4.  Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved.

Authors:  Nicolas W J Schröder; Siegfried Morath; Christian Alexander; Lutz Hamann; Thomas Hartung; Ulrich Zähringer; Ulf B Göbel; Joerg R Weber; Ralf R Schumann
Journal:  J Biol Chem       Date:  2003-02-19       Impact factor: 5.157

5.  Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation endproducts and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: comparison with aminoguanidine.

Authors:  Yasotha Duraisamy; John Gaffney; Mark Slevin; Christopher A Smith; Kenneth Williamson; Nessar Ahmed
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

6.  Up-regulation of human beta-defensin 2 by interleukin-1beta in A549 cells: involvement of PI3K, PKC, p38 MAPK, JNK, and NF-kappaB.

Authors:  Byeong-Churl Jang; Ki-Jo Lim; Ji-Hye Paik; Young-Kyu Kwon; Sang-Woo Shin; Sang-Chan Kim; Tae-Young Jung; Taeg Kyu Kwon; Jae-We Cho; Won-Ki Baek; Sang-Pyo Kim; Min-Ho Suh; Seong-Il Suh
Journal:  Biochem Biophys Res Commun       Date:  2004-07-30       Impact factor: 3.575

7.  Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control.

Authors:  S J Gallacher; G Thomson; W D Fraser; B M Fisher; C G Gemmell; A C MacCuish
Journal:  Diabet Med       Date:  1995-10       Impact factor: 4.359

Review 8.  Molecular understanding of hyperglycemia's adverse effects for diabetic complications.

Authors:  Matthew J Sheetz; George L King
Journal:  JAMA       Date:  2002-11-27       Impact factor: 56.272

9.  Quantifying the risk of infectious diseases for people with diabetes.

Authors:  Baiju R Shah; Janet E Hux
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

10.  Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes.

Authors:  Kazushige Midorikawa; Kazuhisa Ouhara; Hitoshi Komatsuzawa; Toshihisa Kawai; Sakuo Yamada; Tamaki Fujiwara; Kenshi Yamazaki; Koji Sayama; Martin A Taubman; Hidemi Kurihara; Koji Hashimoto; Motoyuki Sugai
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more
  15 in total

1.  Salivary levels of hBDs in children and adolescents with type 1 diabetes mellitus and gingivitis.

Authors:  Dogukan Yilmaz; Neslihan Yilmaz; Recep Polat; Verneri Nissilä; Elif Gül Aydın; Jaana Rautava; Mervi Gürsoy; Ulvi Kahraman Gürsoy
Journal:  Clin Oral Investig       Date:  2022-03-21       Impact factor: 3.606

2.  Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity.

Authors:  H Brauner; P Lüthje; J Grünler; N R Ekberg; G Dallner; K Brismar; A Brauner
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

3.  Gingival crevicular fluid levels of human beta-defensin-1 in type 2 diabetes mellitus and periodontitis.

Authors:  Dogukan Yilmaz; Feriha Caglayan; Esra Buber; Eija Könönen; Yasemin Aksoy; Ulvi Kahraman Gursoy; Guliz N Guncu
Journal:  Clin Oral Investig       Date:  2018-04-30       Impact factor: 3.573

4.  High glucose inhibits ClC-2 chloride channels and attenuates cell migration of rat keratinocytes.

Authors:  Fuqiang Pan; Rui Guo; Wenguang Cheng; Linlin Chai; Wenping Wang; Chuan Cao; Shirong Li
Journal:  Drug Des Devel Ther       Date:  2015-08-28       Impact factor: 4.162

5.  Histone deacetylase-mediated regulation of the antimicrobial peptide hBD2 differs in intestinal cell lines and cultured tissue.

Authors:  Sabrina Stebe-Frick; Maureen J Ostaff; Eduard F Stange; Nisar P Malek; Jan Wehkamp
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

6.  A novel lipopeptide from skin commensal activates TLR2/CD36-p38 MAPK signaling to increase antibacterial defense against bacterial infection.

Authors:  Dongqing Li; Hu Lei; Zhiheng Li; Hongquan Li; Yue Wang; Yuping Lai
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

7.  High-glucose environment enhanced oxidative stress and increased interleukin-8 secretion from keratinocytes: new insights into impaired diabetic wound healing.

Authors:  Cheng-Che E Lan; Ching-Shuang Wu; Shu-Mei Huang; I-Hui Wu; Gwo-Shing Chen
Journal:  Diabetes       Date:  2013-02-19       Impact factor: 9.461

8.  Acute hyperglycemia impairs IL-6 expression in humans.

Authors:  Matthew P Spindler; Alvin M Ho; David Tridgell; Marli McCulloch-Olson; Vivian Gersuk; Chester Ni; Carla Greenbaum; Srinath Sanda
Journal:  Immun Inflamm Dis       Date:  2016-01-19

9.  The Effect of Candida albicans on the Expression Levels of Toll-like Receptor 2 and Interleukin-8 in HaCaT Cells Under High- and Low-glucose Conditions.

Authors:  Di Wang; Yong Jiang; Zhuoran Li; Lu Xue; Xiaoting Li; Yuanjun Liu; Chunli Li; Huiping Wang
Journal:  Indian J Dermatol       Date:  2018 May-Jun       Impact factor: 1.494

10.  Trisk 95 as a novel skin mirror for normal and diabetic systemic glucose level.

Authors:  Nsrein Ali; Hamid Reza Rezvani; Diana Motei; Sufyan Suleman; Walid Mahfouf; Isabelle Marty; Veli-Pekka Ronkainen; Seppo J Vainio
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.